Answers are grounded in this paper and cite their sources.
This medical hypothesis proposes a paradigm shift in hypertension management from focusing solely on peripheral vascular resistance (V = IR) to regulating blood pressure to maintain functional bioenergy requirements in tissues (W = VI).
Blood pressure is expressed as V (blood pressure) = I (circulating blood volume or cardiac output) × R (peripheral vascular resistance), based on Ohm’s law (V (voltage) = I (current) × R (resistance)). Antihypertensive drugs that reduce either I or R are used. On the other hand, the electrical energy consumed per unit time is power (W), which is expressed as W = VI. If we consider the energy consumed by each organ to be W, and assume that an organ consumes a constant amount of functional bioenergy requirement (FBR), then V and I work in a complementary manner. It is conceivable that if a decrease in blood flow occurs first due to conditions such as arteriosclerosis or peripheral circulatory failure, peripheral blood pressure will rise compensatorily; conversely, if systemic blood pressure rises first, tissue blood flow will decrease compensatorily, potentially leading to chronic ischemia. In this medical hypothesis, I would like to consider a shift in perspective from V = IR to W = VI in blood pressure management—a field that has traditionally focused on peripheral vascular resistance (R)—by shifting the focus to blood pressure regulation aimed at maintaining FBR in tissues.
No takes yet. Share an insight, caveat, or question.
Mogi et al. (2026) conducted an editorial in Hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: